International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants.

The OBSTINATE registry.

(OBServaToire INternational des patients trait├ęs par Anticoagulants oraux directs au cours du syndrome des anTiphospholipidEs)

Registry supported by the European Forum on Antiphospholipid Antibodies and the Lupus Anticoagulant/Antiphospholipid Antibodies Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Inclusion criteria: All thrombotic APS patients according to Sydney criteria treated with a direct oral anticoagulant (rivaroxaban, apixaban, edoxaban, dabigatran).

To participate and to include a patient:

- Contact: Prof. S. Zuily

- Website: electronic CRF (available soon)